Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ocular Telehealth Management (OTM) was a diagnostic telemedicine company specializing in the remote examination and management of ocular disorders, with a primary focus on diabetic retinopathy. Established as a joint venture between Escalon Medical Corp. and a former board member, the company utilized digital imaging and telecommunications software to provide annual dilated retinal examinations for diabetic patients in primary care settings. OTM's technology was designed to improve patient access to specialized eye care and facilitate early disease detection through a distributed screening model. The company's solutions aimed to harness advances in digital imaging to create a more successful disease management system for populations susceptible to ocular disease. While active in the late 2000s and early 2010s, the company is no longer highlighted as a primary operating unit of its parent company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ocular Telehealth Management.